Related Experiment Video
Updated: Aug 31, 2025

Experimental and Imaging Techniques for Examining Fibrin Clot Structures in Normal and Diseased States
Published on: April 1, 2015
Managing thrombotic risk in patients with diabetes
A John Camm1, Hani Sabbour2,3, Oliver Schnell4
1Division of Cardiac and Vascular Sciences, Molecular and Clinical Sciences Research Institute, St George's, University of London, London, Cranmer Terrace, SW17 0RE, UK. jcamm@sgul.ac.uk.
Diabetes significantly increases cardiovascular risk, especially with atrial fibrillation (AF). Non-vitamin K antagonist oral anticoagulants show promise for stroke prevention in these high-risk diabetic patients.
Area of Science:
- Cardiology
- Endocrinology
- Pharmacology
Background:
- Diabetes mellitus is a major independent risk factor for cardiovascular (CV) events, including atrial fibrillation (AF).
- Patients with diabetes exhibit a prothrombotic and inflammatory state, elevating their risk for thromboembolic events.
- Comorbidities like AF and coronary artery disease are prevalent in diabetic populations, compounding CV risk.
Purpose of the Study:
- To review CV risk management strategies for patients with diabetes and concurrent vascular disease.
- To examine stroke prevention regimens for diabetic individuals with AF.
- To discuss the impact of renal function on these therapeutic approaches.
Main Methods:
- Review of clinical trials and real-world evidence.
- Analysis of guideline recommendations for CV risk factor control.
- Discussion of antithrombotic agent efficacy in high-risk diabetic patients.
Main Results:
- Non-vitamin K antagonist oral anticoagulants (NOACs) demonstrate benefit in stroke prevention for patients with diabetes and AF.
- Optimal CV risk factor control, including anticoagulation, is recommended.
- Worsening renal function can complicate treatment strategies.
Conclusions:
- NOACs represent a valuable option for stroke prevention in diabetic patients with AF.
- Tailored risk management strategies are crucial for this high-risk population.
- Further research into innovative drug combinations may enhance outcomes.
More Related Videos
05:06Author Spotlight: Integrating Tai Chi with Mindfulness Training to Achieve an Effective Mind-Body Exercise
Published on: July 14, 2023
07:22Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
Published on: March 7, 2025
Related Concept Videos
Venous Thrombosis IV: Nursing Management
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Venous Thrombosis III: Interprofessional Care
Pulmonary Embolism III: Nursing Management
Peripheral Artery Disease V: Postoperative Nursing Management
Atherosclerosis III: Management